Osaic Holdings’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
Osaic Holdings's HAE Position: Q3 2026 in Review
Osaic Holdings reduced its Haemonetics (HAE) stake by 2% in Q3 2026, selling an estimated $465 and leaving 248 shares worth $26.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5983.
Osaic Holdings first reported a position in HAE in Q1 2020 and has held it in 26 quarters since. The position peaked at $225K in Q4 2020. 361 funds tracked by Wall St. Rank hold HAE as of Q3 2026.
- Osaic Holdings held 248 shares of Haemonetics worth $26.2K as of Q3 2026.
- Osaic Holdings sold 5 Haemonetics shares in Q3 2026, an estimated $465.
- Haemonetics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #5983 holding.
- Osaic Holdings first reported a position in Haemonetics in Q1 2020 and has held it in 26 quarters since.
- Osaic Holdings's Haemonetics position peaked at $225K in Q4 2020.
- 361 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.